Perspective Therapeutics, Inc. (CATX) Debt by Year
Perspective Therapeutics, Inc. carried $1.6M in long-term debt against $30.6M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 3.1% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Perspective Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CATX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $1.6M-3.1% | $1.7M-2.8% | $1.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $30.6M-50.3% | $61.6M+566.6% | $9.2M-56.0% | $21.0M-67.1% | $63.8M+2568.4% | $2.4M-55.1% | $5.3M+104.8% | $2.6M-56.2% | $5.9M-41.5% | $10.1M+94.0% | $5.2M-31.9% | $7.7M+164.8% | $2.9M+8.5% | $2.7M+26.5% | $2.1M |
CATX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $1.6M-3.3% | $1.6M-3.2% | $1.6M-3.1% | $1.6M-3.0% | $1.7M-3.2% | $1.7M-2.9% | $1.7M-2.8% | $1.7M-2.8% | $1.7M-3.8% | $1.7M-4.5% | $1.7M | $1.7M |
| Cash & Equivalents | $48.5M+68.1% | $54.0M+21.5% | $30.6M-50.3% | $26.8M-88.2% | $28.8M-88.6% | $44.4M-68.8% | $61.6M+566.6% | $226.4M+1159.2% | $252.0M+789.9% | $142.1M+289.9% | $9.2M-56.0% | $18.0M-5.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Perspective Therapeutics, Inc. financials
Frequently Asked Questions
What was Perspective Therapeutics, Inc.'s long-term debt in fiscal year 2025?
Perspective Therapeutics, Inc. carried $1.6M in long-term debt against $30.6M in cash and equivalents at the end of fiscal year 2025.
How fast is Perspective Therapeutics, Inc.'s long-term debt growing?
Perspective Therapeutics, Inc. (CATX) long-term debt fell by 3.1% year over year, from $1.7M to $1.6M in fiscal year 2025.
What was Perspective Therapeutics, Inc.'s long-term debt in the most recent quarter?
Perspective Therapeutics, Inc. (CATX) reported $1.6M in long-term debt in Q2 2026. This represents a decrease of 3.3% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Perspective Therapeutics, Inc. (CATX) reported on that line in every period on record.